Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Calibre Chemicals, a leading nutrition, pharmaceuticals, and personal care specialty chemicals company, announced that it has reached an agreement with the proprietors of Bengaluru-based Tina Life Sciences, to acquire Tina's laboratory and product development business with immediate effect.
With this acquisition, Calibre has taken a step forward to further enhance its R&D capabilities, especially in the field of complex organic chemistry. Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Dr. Pintoo Ganguly, an accomplished chemist having diverse experience in developing products and processes in the Indian chemical industry, would lead Caibre's R&D activities.
"We are excited to accredit broader and newer R&D capabilities and welcome Dr. Ganguly and his team to Calibre family," said Deepak Chander, CEO of Calibre Chemicals. "Our collective expertise and knowledge of organic synthesis, electrochemistry, process development, and manufacturing excellence, will enable us in serving our valued customers better."
Calibre R&D centre is based in Bengaluru, India, and another laboratory-cum-pilot-plant at our manufacturing facility in Sarigam, Gujarat.
Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2023 on 13-14 July 2023, Novotel Mumbai International Airport, Mumbai
Tamilnadu Petroproducts gets India's First BIS certification under IS 12795: 2020 for high-quality LAB Production
Creating policy and regulatory frameworks could accelerate the green hydrogen ecosystem: B. S. Bhalla
Merck partners with California-based research group to study catalysis innovation through machine learning
Subscribe To Our Newsletter & Stay Updated